SIRT1 rs12778366, FGFR2 rs2981582, STAT3 rs744166, LIPC rs10468017, rs493258 and LPL rs12678919 genotypes and haplotype evaluation in patients with age-related macular degeneration.


Journal

Gene
ISSN: 1879-0038
Titre abrégé: Gene
Pays: Netherlands
ID NLM: 7706761

Informations de publication

Date de publication:
20 Feb 2019
Historique:
received: 20 05 2018
revised: 11 10 2018
accepted: 01 11 2018
pubmed: 7 11 2018
medline: 9 1 2019
entrez: 7 11 2018
Statut: ppublish

Résumé

Age-related macular degeneration (AMD) is the leading cause of blindness in elderly individuals in the developed countries. The etiology of AMD is thought to be multifactorial, including environmental and genetic factors. Our purpose was to determine the genotype frequencies of six different SNPs in genes that encode proteins involved in AMD-related molecular changes (SIRT1 rs12778366, FGFR2 rs2981582, STAT3 rs744166, LIPC rs10468017, rs493258 and LPL rs12678919) for evaluation of haplotype risk in patients with AMD. The study cohort consisted of 652 AMD patients and 829 healthy controls. The genotyping was carried out using the RT-PCR. TT genotype of the LIPC rs493258 polymorphism was associated with decreased odds of early AMD development under the codominant and recessive models (OR = 0.446; 95% CI: 0.258-0.772; p = 0.004 and OR = 0.455; 95% CI: 0.274-0.756; p = 0.002, respectively) after Bonferroni correction, (p > 0.05/6, since we analyzed 6 different SNPs). The haplotype containing the two minor alleles T-T in rs10468017-rs493258 were significantly (p = 0.034) associated with early AMD development decreasing. There were no associations found with atrophic AMD development. The study showed that LIPC rs493258 gene and haplotype containing the two minor alleles T-T in rs10468017-rs493258 may decrease AMD development.

Identifiants

pubmed: 30399423
pii: S0378-1119(18)31142-9
doi: 10.1016/j.gene.2018.11.004
pii:
doi:

Substances chimiques

LIPC protein, human 0
STAT3 Transcription Factor 0
STAT3 protein, human 0
FGFR2 protein, human EC 2.7.10.1
Receptor, Fibroblast Growth Factor, Type 2 EC 2.7.10.1
Lipase EC 3.1.1.3
LPL protein, human EC 3.1.1.34
Lipoprotein Lipase EC 3.1.1.34
SIRT1 protein, human EC 3.5.1.-
Sirtuin 1 EC 3.5.1.-

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8-15

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Auteurs

Rasa Liutkeviciene (R)

Department of Ophthalmology, Lithuanian University of Health Sciences, Medical Academy, Eiveniu 2 str., Kaunas LT-50161, Lithuania; Neuroscience Institute, Lithuanian University of Health Sciences, Medical Academy, Eiveniu str. 2, Kaunas LT-50161, Lithuania. Electronic address: rasa.liutkeviciene@lsmuni.lt.

Alvita Vilkeviciute (A)

Neuroscience Institute, Lithuanian University of Health Sciences, Medical Academy, Eiveniu str. 2, Kaunas LT-50161, Lithuania; Lithuanian University of Health Sciences, Medical Academy, Eiveniu 2 str., Kaunas LT-50161, Lithuania.

Loresa Kriauciuniene (L)

Department of Ophthalmology, Lithuanian University of Health Sciences, Medical Academy, Eiveniu 2 str., Kaunas LT-50161, Lithuania; Neuroscience Institute, Lithuanian University of Health Sciences, Medical Academy, Eiveniu str. 2, Kaunas LT-50161, Lithuania.

Vytenis Pranas Deltuva (VP)

Neuroscience Institute, Lithuanian University of Health Sciences, Medical Academy, Eiveniu str. 2, Kaunas LT-50161, Lithuania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH